Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.34 CHF | +0.26% | -0.65% | +19.51% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Evolution of the average Target Price on Sandoz Group AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Sandoz Group AG
alphavalue | Abhishek Raval |
UBS | |
Stifel Nicolaus | |
JPMORGAN | James Gordon |
MORGAN STANLEY | Thibault Boutherin |
BERENBERG | Victoria Lambert |
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SDZ Stock
- Consensus Sandoz Group AG